• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
IDEXX Laboratories, Inc. (IDXX) Stock Price, News & Analysis

IDEXX Laboratories, Inc. (IDXX) Stock Price, News & Analysis

Currency in USD Disclaimer

$418.56

-$0.05

(-0.01%)

Day's range
$398.5
Day's range
$419.79
50-day range
$398.5
Day's range
$530.6
  • Country: US
  • ISIN: US45168D1046
52 wk range
$398.5
Day's range
$583.39
  • CEO: Mr. Jonathan J. Mazelsky
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 16.24
  • Piotroski Score 7.00
  • Grade Overweight
  • Symbol (IDXX)
  • Company IDEXX Laboratories, Inc.
  • Price $418.56
  • Changes Percentage (-0.01%)
  • Change -$0.05
  • Day Low $398.50
  • Day High $419.79
  • Year High $583.39

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/03/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $536.50
  • High Stock Price Target $600.00
  • Low Stock Price Target $247.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $10.31
  • Trailing P/E Ratio 48.26
  • Forward P/E Ratio 48.26
  • P/E Growth 48.26
  • Net Income $845.04 M

Income Statement

Quarterly

Annual

Latest News of IDXX

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

IDEXX Laboratories, Inc. Frequently Asked Questions

  • What were the earnings of IDXX in the last quarter?

    In the last quarter IDEXX Laboratories, Inc. earnings were on Thursday, October, 31st. The IDEXX Laboratories, Inc. maker reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.68 by $0.12.

  • What is the IDEXX Laboratories, Inc. stock price today?

    Today's price of IDEXX Laboratories, Inc. is $418.56 — it has decreased by -0.01% in the past 24 hours. Watch IDEXX Laboratories, Inc. stock price performance more closely on the chart.

  • Does IDEXX Laboratories, Inc. release reports?

    Yes, you can track IDEXX Laboratories, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the IDEXX Laboratories, Inc. stock forecast?

    Watch the IDEXX Laboratories, Inc. chart and read a more detailed IDEXX Laboratories, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is IDEXX Laboratories, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by IDEXX Laboratories, Inc. stock ticker.

  • How to buy IDEXX Laboratories, Inc. stocks?

    Like other stocks, IDXX shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is IDEXX Laboratories, Inc.'s EBITDA?

    IDEXX Laboratories, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in IDEXX Laboratories, Inc.’s financial statements.

  • What is the IDEXX Laboratories, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.2308256894, which equates to approximately 23.08%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in IDEXX Laboratories, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including IDEXX Laboratories, Inc.'s financials relevant news, and technical analysis. IDEXX Laboratories, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for IDEXX Laboratories, Inc. stock currently indicates a “sell” signal. For more insights, review IDEXX Laboratories, Inc.’s technical analysis.

  • A revenue figure for IDEXX Laboratories, Inc. for its last quarter?

    IDEXX Laboratories, Inc. published it's last quarterly revenues at $975.54 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.